Literature DB >> 7229802

Newborn tracheal aspirate cytology: classification during respiratory distress syndrome and bronchopulmonary dysplasia.

T A Merritt, I D Stuard, J Puccia, B Wood, D K Edwards, J Finkelstein, D L Shapiro.   

Abstract

Cytopathologic examinations of tracheobronchial aspirates from 108 infants sampled during mechanical ventilation demonstrated a well-defined progression of cytologic changes in bronchial cells that could be divided into three classes. Seventy percent of infants with respiratory distress syndrome who developed bronchopulmonary dysplasia had pulmonary effluent cytology designated Class III; no infants with RDS but without BPD had these cytologic findings. Additionally, a temporal progression of events involving polymorphonuclear leukocyte and macrophage populations occurred in the absence of infection; these events were associated with duration of assisted ventilation and oxygen exposure. The technique described provides a useful way to monitor the progression of lung injury and repair and offers a cytologic method to predict and diagnose the development of bronchopulmonary dysplasia.

Entities:  

Mesh:

Year:  1981        PMID: 7229802     DOI: 10.1016/s0022-3476(81)80603-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  25 in total

1.  Follow up of a randomised trial of two different courses of dexamethasone for preterm babies at risk of chronic lung disease.

Authors:  D L Armstrong; J Penrice; F H Bloomfield; D B Knight; J A Dezoete; J E Harding
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-03       Impact factor: 5.747

Review 2.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 3.  Bronchopulmonary dysplasia: early diagnosis, prophylaxis, and treatment.

Authors:  A Greenough
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

4.  Microscopic observations on tracheal aspirates from ventilated neonates. II. The onset of bronchopulmonary dysplasia and other changes.

Authors:  W Jacobson; C J Morley; M South
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

Review 5.  Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease?

Authors:  C M Harrison; C C Andersen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

6.  Type I collagenases in bronchoalveolar lavage fluid from preterm babies at risk of developing chronic lung disease.

Authors:  D G Sweet; K J McMahon; A E Curley; C M O'Connor; H L Halliday
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

Review 7.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

8.  Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia.

Authors:  K Tullus; G W Noack; L G Burman; R Nilsson; B Wretlind; A Brauner
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

9.  Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease.

Authors:  T Bhuta; A Ohlsson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-07       Impact factor: 5.747

10.  Prediction of individual response to postnatal dexamethasone in ventilator dependent preterm infants.

Authors:  C Kuschel; N Evans; A Lam
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-05       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.